Bushen Huoxue acupuncture ameliorates Alzheimer’s disease by upregulating MARCHF3 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis Authors: Hong Zhu, Ting Zhang, Ruomeng Li, Dan Ren, Jiangxi Xu, Lan Xiao Published: 2024 ABSTRACT AbstractAlzheimer’s disease (AD) is a common neurodegenerative disorder that places a heavy burden on patients and society. Hippocampal neuronal loss is a hallmark of AD progression. Therefore, understanding the mechanism underlying hippocampal neuronal death would be of great importance for the diagnosis and treatment of AD. This study aimed to explore the molecular mechanism via which Bushen Huoxue Acupuncture inhibits hippocampal neuronal pyroptosis in AD. Senescence-accelerated mouse prone 8 (SAMP8) mice were used as a model of AD. Bushen Huoxue Acupuncture was performed in four acupoints: “Baihui acupoint” (GV20), “Shenshu acupoint” (BL23), “Xuehai acupoint” (SP10), and “Geshu acupoint” (BL17). Morris water maze was used to test cognitive function in mice. IHC staining was used to test mice’s Aβ1–42, MARCHF1 and MARCHF3 expression. Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) staining was used for observing hippocampal neuronal apoptosis. The mRNA expression levels of pyroptosis markers MARCHF1, MARCHF3, NLRP3, caspase-1, GSDMD, IL-1β, and IL-18 mRNA in AD mice were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The protein expression of NLRP3, caspase-1 and GSDMD-N was tested by Western blotting. IL-1β and IL-18 protein levels were measured by Enzyme-Linked Immunosorbent Assay (ELISA). SH-SY5Y cells were used to establish an AD model following Aβ1−42 treatment. Western blot was used to detect the NLRP3, MARCHF1 and MARCHF3 proteins following Aβ1−42 treatment. The endogenous Co-IP assay in combination with immunoblotting for ubiquitin signals was used to detect of NLRP3 ubiquitination level. We found that Bushen Huoxue Acupuncture protected cognitive impairment in AD mice. Bushen Huoxue Acupuncture inhibited hippocampal neuronal pyroptosis and the secretion of inflammatory cytokines in vivo. In SH-SY5Y cells, we found that Aβ1−42 decreased the binding of E3 ubiquitin-protein ligase MARCHF1 or MARCHF3 with NLRP3, and the ubiquitination of NLRP3. In conclusion, Bushen Huoxue Acupuncture ameliorates AD by upregulating MARCHF3 to induce NLRP3 ubiquitination and inhibits caspase-1-dependent pyroptosis.Supplementary InformationThe online version contains supplementary material available at 10.1007/s11011-024-01459-9.Keywords: Alzheimer’s disease, Pyroptosis, Bushen Huoxue acupuncture, Hippocampal neurons, Ubiquitination Introduction Alzheimer’s disease is one of the most commonly diagnosed cases of senile dementia in the world (Twarowski and Herbet 2023). In 2016, an estimated 700,000 Americans aged ≥ 65 years died of Alzheimer’s disease. By mid-century, the number of people living with Alzheimer’s disease (AD) in the United States is projected to grow to 13.8 million (Association 2016). There are notable increasing trends in the number of deaths (247.9%), incidence (264.8%), and prevalence (296.5%) of Alzheimer’s disease in China (Li et al. 2022). AD is a neurodegenerative disorder characterized by progressive cognitive decline, amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles composed of hyperphosphorylated tau (Qiu et al. 2023). Accumulation of Aβ is thought to be associated with the progressive neuronal death observed in AD (Wan et al. 2010). Aβ can also suppress Bcl-2 and induce neuronal cell apoptosis in Alzheimer’s disease (Kim et al. 2020). Truncated tau protein is a new marker for Alzheimer’s disease, and one practicable strategy for AD drug design is to discover compounds that could inhibit tau protein aggregation and/or phosphorylation (Novák 1994; Xiao et al. 2021). The alleviation of AD by escitalopram is mainly associated with a significant decrease in tau hyperphosphorylation and increased numbers of neurons (Wang et al. 2020). Resveratrol ameliorates tau hyperphosphorylation at Ser396 site and may serve as a potential nutraceutical agent for AD (Jhang et al. 2017). However, the mechanism of AD is still unclear. Acupuncture can improve the cognitive state of Alzheimer’s disease (Wang et al. 2021). Electroacupuncture activates TFEB-mediated lysosomal biogenesis and improves memory in an AD animal model (Zheng et al. 2021). Acupuncture improves spatial learning and memory ability of middle-aged SAMP8 mice by ameliorating dendritic structure (Kan et al. 2018). Electroacupuncture ameliorates spatial learning and memory impairment via attenuating oxidative stress in a rat model of AD (Wu et al. 2017). Electroacupuncture improves learning/memory in AD rats by upregulating the autophagy pathway (Guo et al. 2016). Bushen Huoxue Acupuncture was performed in four acupoints of “Baihui”, “Shenshu”, “Xuehai”, and “Geshu” by manual acupuncture. In our previous study, we showed that Bushen Huoxue Acupuncture inhibits neuronal pyroptosis in the SAMP8 mouse model of AD (Rao et al. 2022). However, its clinical effects and underlying mechanisms are not fully understood. In this study, we aimed to investigate whether Bushen Huoxue Acupuncture could ameliorate AD and elucidate the underlying mechanism using in vivo and in vitro models of AD. Collectively, our findings suggest that Bushen Huoxue Acupuncture ameliorates hippocampal neuronal pyroptosis via NLRP3/caspase-1/GSDMD in SAMP8 mice. Furthermore, we propose that Bushen Huoxue Acupuncture could potentially be a promising new therapeutic drug for treating AD. Materials and methods Cell culture SH-SY5Y cells were maintained in a high-glucose Dulbecco’s Modified Eagle Medium (DMEM) (11965118, Gibco) containing 10% fetal bovine serum (FBS), 100 unit/mL penicillin and 100 µg/mL streptomycin at 37 °C with 5% CO2. To investigate whether MARCHF1 or MARCHF3 mediated the regulatory effect of Aβ1−42 in SH-SY5Y cells, we treated the cells with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 48 h after transfection, the cells were harvested. Cell cultures and treatments were used for in vitro experiments. Animals Forty female SAMP8 mice aged 7 weeks and ten age-matched SAMR1 mice weighing 26–30 g were obtained from the SPF Biotechnology Co. Ltd (Beijing, China). The mice were placed in controlled environments (12-h light/dark cycle; 20 ~ 23 °C; 55 ~ 58% humidity) and had free access to enough food and water. All animal experiments were conducted with the approval of the Experimental Animal Ethics Committee of The Third Xiangya Hospital of Central South University. All protocols were performed under conditions to minimize animal suffering. After one week of adaptation feeding, forty female SAMP8 mice were randomly divided into four groups utilizing the RANDBETWEEN function in Microsoft Excel, which generated random numbers: AD model group, AD + Nonacupuncture group, AD + Acupuncture group and AD + DNP group. Mice in the nonacupuncture control group were treated by stimulating the fixed non-point, while mice in the acupuncture control group were treated by stimulating the fixed point. Mice in the AD model group and normal control group were raised without special treatment but administered the stimulation of catching with the same time and the same stimulus intensity. The AD + DNP group mice were given the donepezil (DNP, 1 mg/kg/d) intragastrically for 8 weeks. Acupuncture treatment Acupuncture Treatment was carried out with the method in this article (Zhang et al. 2021). Mice in the acupuncture group were intervened by Bushen Huoxue Acupuncture into the acupoints of “Baihui acupoint” (GV20), “Shenshu acupoint” (BL23), “Xuehai acupoint” (SP10) and “Geshu acupoint” (BL17). At GV20, the needle was inserted obliquely to a depth of 3–4 mm. At BL23 and SP10, the needle was inserted perpendicularly to 2–3 mm depth. At BL17, the needle was inserted obliquely upward at an angle of 80° to 2–3 mm depth. For BL23, SP10 and BL17, the left side was acupunctured first, and then the right side was acupunctured the next day. Mice in the nonacupuncture control group were treated by stimulating the fixed non-point under the bilateral rib, while mice in the AD model group and normal control group were raised without special treatment but administered the stimulation of catching at the same time and the same stimulus intensity. All mice were intervened daily for 6 consecutive days, followed by one day of rest, for 8 consecutive weeks. Animal models were used for in vivo experiments. Morris water maze test The Morris water maze test comprised six days of navigation experiments, followed by the 7th day of space exploration experiments. The positioning navigation experiment lasted for 6 days. Once a day, the mice were placed in the water facing the pool wall and recorded time to find the platform (escape latency) and the swimming pathway within 120 s time. Space exploration experiments were conducted in the morning. Remove the platform and drop the mice into the water from a random quadrant facing the pool wall. The track of mice searching for the original platform and its quadrant swimming time over the original platform were recorded within 120s. IHC for Aβ1−42, MARCHF1 and MARCHF3 Hippocampus samples were fixed by formalin and embedded in paraffin. Slides were deparaffinized and rehydrated via successive immersion in the following solutions: xylene I (15 min), xylene II (15 min), ethanol absolute I (5 min), ethanol absolute II (5 min), 95% ethanol (5 min), 80% ethanol (5 min), double distilled water I (5 min), and double-distilled water II (3 min). The slides were then boiled in 0.01 M citrate buffer for 15 min and washed with PBS (5 min) twice. Non-specific binding was blocked by incubating sections with 5% BSA. Sections were then incubated with primary antibody Aβ1−42 (24090 S, CST), MARCHF1(PA5-53199, Invitrogen) and MARCHF3 (PA5-101570, Invitrogen) overnight, followed by HRP-labeled goat anti-rabbit/mouse secondary antibody for 30 min at room temperature. DAB (G1212-200T, servicebio) was used for color development. Finally, these sections were observed with a microscope (Leica, Germany). The percentage of Aβ1−42, MARCHF1 and MARCHF3 expression was quantified by Image J software. Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) staining TUNEL assay was performed to determine the apoptotic rates of the cell in the hippocampus region of the mouse using Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) kit (G1507-50T, Servicebio) according to the manufacturer’s instructions. Briefly, the sections were deparaffinized with xylene, and treated with a graded series of alcohol (100%, 85% and 75% ethanol in double-distilled H2O) and rehydrated in PBS. Then the tissues were treated with proteinase K solution for permeabilization. Slides were treated with the TdT reaction mix and incubated at 37 °C for 1 h and washed with PBS (5 min) four times. The endogenous peroxidase was blocked with 0.3% hydrogen peroxide and was incubated with streptavidin-HRP for 30 min at room temperature and then colorized diaminobenzidine (DAB). Nuclei were counterstained with hematoxylin and the sections were visualized and captured under a fluorescent microscope (Leica, Germany). TUNEL-positive cells were expressed as a percentage. In vivo NLRP3 ubiquitination assay Myc-NLRP3, HA-Ub plasmids were transfected into SH-SY5Y cells with lipofectamine reagent. SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h and 20 µM MG132 for 8 h before being harvested. The cells were washed with PBS and lysed. The lysates were immunoprecipitated with anti-Myc antibody and protein A/G agarose beads (Santa Cruz) at 4 °C overnight. Then the beads were washed four times with RIPA buffer. The proteins were released from the beads by boiling in SDS–PAGE loading buffer and analysed by immunoblotting with anti-HA antibody. Cell transfection The MARCHF1 and MARCHF3 plasmids were purchased from Gene Pharm (Shanghai, China). The MARCHF1 plasmid (or MARCHF3 plasmid) and Lipofectamine™3000 (L3000015, Invitrogen) were respectively incubated in OPTI-MEM reduced serum medium (31985070, Invitrogen) for 20 min. The mixture of MARCHF1 plasmid (or MARCHF3 plasmid) and Lipofectamine™3000 was transfected to the cells in the plate. The cells were replaced with the normal glucose medium 5 h later. 48 h later, the cells on the plates were harvested for further study. CCK8 assay 5 × 103 SH-SY5Y cells were seeded into one cell of the 96 well plates and cultured for 24 h. 24 h later, the cells in each well were added 10 µL CCK-8 reagent for 4 h incubation in 5% CO2. After 4 h incubation, the optical densities (OD) at 450 nm were measured by a microplate reader (DTX 880, Beckman coulter). Flow Cytometry for cell apoptosis FITC Annexin V Apoptosis Detection Kit I (No.556547, BD) was used to detect cell apoptosis. Cells were collected when they reached the logarithmic growth phase. 1 × 105 cells were suspended with 100 µL Binding Buffer. Next, 5 µL of Annexin-V and 5 µL of Propidium Iodide (PI) were added to the buffer and incubated at room temperature for 15 min in the darkness for Accuri C6 flow cytometer (BD Biosciences, USA) analysis. qRT-PCR Total RNA was isolated using TRIzol Invitrogen (15596018, invitrogen) according to the manufacturer’s instruction and was reverse transcribed by using PrimeScript™ RT reagent Kit (RR037Q, Takara). Quantitative real-time PCR analysis was performed under the following conditions: 30 s at 95 °C followed by 40 cycles at 95 °C for 3s, and 60 °C for 30 s using an Real time PCR system (ABI 7900HT, Applied Biosystems). For quantification of gene expression, the 2−ΔΔCt method was used. GAPDH expression was used for normalization. Primers used in this article are listed in Table 1. Table 1Primers used in qRT-PCRGene(Mouse)Forward sequence (5’-3’)Reverse sequence (5’-3’)APPTCCGAGAGGTGTGCTCTGAACCACATCCGCCGTAAAAGAATGNLRP3ATTACCCGCCCGAGAAAGGCATGAGTGTGGCTAGATCCAAGGSDMDATGCCATCGGCCTTTGAGAAAAGGCTGTCCACCGGAATGACaspase-1TGGAGATGGTGAAAGAGGTGGGTGTTGAAGAGCAGAAAGCIL-1βGAAATGCCACCTTTTGACAGTGTGGATGCTCTCATCAGGACAGIL-18GTGAACCCCAGACCAGACTGCCTGGAACACGTTTCTGAAAGAMARCHF1CCAGATGACCACGAGCGAAAGCGCTGTCCGATCTATCAACACMARCHF2TGGGCCACCTCAATATGTAGCACATGGGGACAGCAAGTTCTCMARCHF3TGAAGACGGTGGAGGATTGTGAAGAGTCCGCACTACTGTTGAMARCHF8TCTGCTAGAGTCTACAGAAGCAAGGAGGACTACTCCCAGCCTTMARCHF9TGCCTAATCCGCTGGATCAGGACGATAGCAGCAATCTGGACMARCHF11CGAAACACGCTCCGTATGTAGCACATCGGCAAGGATTTAACAACGAPDHGCACCGTCAAGGCTGAGAACTGGTGAAGACGCCAGTGGA Primers used in qRT-PCR Western blotting Hippocampal tissues or cultured cells were washed with pre-cooled PBS, then lysed on ice using RIPA Lysis Buffer (P0013B, Beyotime) with a Protease Inhibitor Cocktail (B14001, Selleck) for 30 min and centrifuged at 12,000 g at 4 °C for 15 min. The supernatant was collected and its protein concentration was measured with the Enhanced BCA Protein Assay Kit (P0009, Beyotime). After denaturation, all the proteins were separated by different SDS-PAGE, and transferred to PVDF membranes. The PVDF membranes were then blocked with 5% skim milk for 2 h at room temperature and incubated with primary antibodies NLRP3 (15101, CST), gasdermin D (GSDMD) (ab209845, Abcam), GSDMD-N (DF13758, Affinity), pro-caspase-1 (ab238972, Abcam), cleaved-Caspase 1 (AF4005, Affinity), MARCHF1(PA5-103815, Invitrogen), MARCHF3 (PA5-101570, Invitrogen) and β-actin (ab8226, Abcam) overnight at 4 °C. Then, the membranes were washed three times with TBST and then incubated with the appropriate horseradish peroxidase-labelled secondary antibodies. for 60 min at room temperature. An enhanced chemiluminescence reagent was used to view the reaction. Standardization was performed using β-actin. Elisa The levels of Aβ1−42, IL-1β and IL-18 in SH-SY5Y cells were determined using an ELISA kit (Jonln, Shanghai, China) according to the manufacturer’s instructions. The absorbance of the samples at a wavelength of 450 nm was measured with a BioTek microplate reader. Statistical analysis The two groups’ differences were analyzed using an unpaired two-tailed Student’s t-test. If there were more than two groups, two-way ANOVA with Tukey’s post hoc analysis was used. GraphPad Prism 8.3.0 was used to analyze data and construct the graphs. The data are presented as the mean ± standard deviation (SD) from three independent experiments. p values < 0.05 was considered statistically significant. Results Bushen Huoxue acupuncture improved cognitive deficit and reduced Aβ1−42 level in AD mice To assess the potential effects of acupuncture treatment on Alzheimer’s disease (AD), mice were treated with acupuncture or DNP for 8 weeks, Morris Water Maze test was next used to evaluate the cognitive function of mice (Fig. 1A). In the navigation test, AD mice had a significantly longer escape latency time and poorer ability to find the platform compared to control mice. Importantly, compared with the AD or AD + nonacupuncture group, the AD mice in the acupuncture group showed shorter escape latency time and improved ability to find the platform (Fig. 1B-D). Similarly, the number of crossings over the platform and swimming time in quadrant in the space exploration experiment were decreased in AD mice. AD mice that received Bushen Huoxue Acupuncture treatment showed an increase in the number of crossings over the platform and swimming time in quadrant than mice in the untreated AD group (Fig. 1E-F). The hippocampus, a brain area critical for learning and memory, is especially vulnerable to damage at early stages of AD (Mu and Gage 2011). Furthermore, the production of amyloid precursor protein (APP) and Aβ1−42 was markedly elevated in hippocampus tissues of AD mice compared with the mice in the control group. Bushen Huoxue Acupuncture treatment significantly decreased the AD induced levels of APP and Aβ1−42 (Fig. 1G-H). IHC staining also showed similar results (Fig. 1I-J). TUNEL staining demonstrated that Bushen Huoxue Acupuncture markedly attenuated the AD-induced hippocampal neuronal apoptosis (Fig. 1L-N). These data suggested that Bushen Huoxue Acupuncture could improve brain dysfunction in AD mice. Bushen Huoxue acupuncture improved cognitive deficit and reduced Aβ1−42 Level in AD Mice (A) Animal experimental procedures. (B) Mouse swimming path diagram among 5 groups in the Morris water maze. (C) Comparison of the Swimming speed among 5 groups in the Morris water maze. (D) Comparison of the escape latency time among 5 groups in the Morris water maze. (E) The number of plat-form crossing among 5 groups in the Morris water maze. (F) The swimming time in quadrant among 5 groups in the Morris water maze. (G) QRT-PCR to was used test the APP mRNA level among 5 groups in hippocampal region. (H) ELISA assay was used to test the Aβ1−42 protein level among 5 groups in hippocampal region. (I-J) IHC was used to test the Aβ1−42 protein level among 5 groups in hippocampal region. (K-N) TUNEL staining was used to test hippocampal neuronal apoptosis among 5 groups. Data were presented as the mean value ± SD from at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 Bushen Huoxue acupuncture inhibited NLRP3 inflammasome-mediated pyroptosis in AD mice Bushen Huoxue Acupuncture inhibits neuronal pyroptosis in SAMP8 mouse model of AD (Zhang et al. 2021). To further confirm how Bushen Huoxue Acupuncture modulates pyroptosis, and in turn, intervenes in the pathogenesis of AD, we validated the results obtained from the SAMP8 mice. As expected, qRT-PCR results showed an increase of NLRP3, GSDMD, and Caspase-1 mRNA expression in hippocampus tissues of AD mice. Conversely, these protein expressions were reduced in the AD + Acupuncture group (Fig. 2A-C). Western blotting results showed an increase of NLRP3, cleaved caspase-1 and GSDMD-NT protein expression levels in hippocampus tissues of AD mice. Conversely, these protein expressions were reduced in the AD + Acupuncture group (Fig. 2D-G). As pyroptosis can release inflammation factor IL-1β and IL-18, we next tested the expression of IL-1β and IL-18. The Bushen Huoxue Acupuncture treatment significantly decreased the expression levels of IL-1β and IL-18 in hippocampus area (Fig. 2H-K). These data suggested that Bushen Huoxue Acupuncture inhibited NLRP3 inflammasome mediated hippocampal neuronal pyroptosis in AD Mice. Bushen Huoxue acupuncture inhibited NLRP3 inflammasome-mediated pyroptosis in AD mice (A) QRT-PCR was used to test the NLRP3 mRNA level among 5 groups in hippocampal region. (B) QRT-PCR was used to test the GSDMD mRNA level among 5 groups in hippocampal region. (C) QRT-PCR was used to test the caspase 1 mRNA level in hippocampal region. (D-F) Western blot was used to test the expression of NLRP3 and cleaved-caspase1 protein expression in hippocampal region. (G) Western blot was used to test the expression of GSDMD-NT protein expression in hippocampal region. (H). QRT-PCR was used to test the IL-1β mRNA level among 5 groups in hippocampal region. (I) QRT-PCR was used to test the IL-18 mRNA level among 5 groups in hippocampal region. (J) ELISA was used to test the expression of IL-1β among 5 groups in hippocampal region. (K) ELISA was used to test the expression of IL-18 in 5 groups hippocampal region. Data were presented as the mean value ± SD from at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 Aβ1−42 decreased the binding of MARCHF1 or MARCHF3 to NLRP3 in SH-SY5Y cells AD is a neurodegenerative disorder characterized by Aβ plaques and treatment SH-SY5Y cells with 10 µM Aβ1−42 for 24 h induced neurotoxicity (Li et al. 2018). To explore the underlying mechanisms of Aβ1−42 induced SH-SY5Y cell damage, qRT-PCR and Western blot were applied to determine the mRNA and protein expression of NLRP3. Results indicated that Aβ1−42 considerably increased the expression of NLRP3 in SH-SY5Y cells (Fig. 3A-B). NLRP3 can be polyubiquitination and proteasomal degradation by E3 ubiquitin ligase enzyme (Song et al. 2016). The endogenous Co-IP assay coupled with immunoblotting for ubiquitin signals demonstrated that Aβ1−42 decreased the NLRP3 total polyubiquitination level (Fig. 3C). Ubibrowser 2.0 shows that MARCHF1, MARCHF2, MARCHF3, MARCHF8, MARCHF9 and MARCHF11 might be the E3 ubiquitin ligase enzyme of NLRP3 (Fig. 3D). QRT-PCR results showed that Membrane-associated RING‐CH‐1 (MARCHF1) and MARCHF3 had the lower expression compared with other E3 ubiquitin ligase enzyme after Aβ1−42 treatment. So we chose these two enzymes for further studies (Fig. 3E). Western blot results also showed that Aβ1−42 decreased the MARCHF1 and MARCHF3 protein expression (Fig. 3F-G). Co-IP assay showed that MARCHF1 or MARCHF3 could bind to NLRP3, but Aβ1−42 decreased the binding of MARCHF1 or MARCHF3 to NLRP3 (Fig. 3H). All these data suggested that Aβ1−42 decrease the binding of E3 ubiquitin-protein ligase MARCHF1 or MARCHF3 with NLRP3, and the ubiquitination of NLRP3. Aβ1−42 decreased the binding of MARCHF1 or MARCHF3 to NLRP3 in SH-SY5Y cells (A) QRT-PCR was used to test the NLRP3 mRNA level in SH-SY5Y cells after Aβ1−42 treatment. (B) Western blot was used to test the NLRP3 protein expression level in SH-SY5Y cells after Aβ1−42 treatment. (C) Aβ1−42 decreased the NLRP3 total polyubiquitination level. SH-SY5Y cells were treated with 0.5 µg HA-Ub plasmid, myc-NLRP3 plasmid and 10 µM Aβ1−42 upon MG132 treatment for h and then immunoblotted with the indicated antibodies. (D) Ubibrowser 2.0 was used to predict the E3 ubiquitin ligase enzyme that might interact with NLRP3. (E) QRT-PCR was used to test the MARCHF1 and MARCHF3 expression after Aβ1−42 treatment. (F-G) Western blot was used to test the MARCHF1 and MARCHF3 protein expression levels in SH-SY5Y cells after Aβ1−42 treatment. (H) An immunoprecipitation assay was used to show the endogenous interaction between MARCHF1 or MARCHF3 and NLRP3. For examining the endogenous interaction between MARCHF1 or MARCHF3 and NLRP3, lysates of SH-SY5Y cells were precipitated with anti-NLRP3 antibodies, and the precipitates were examined by immunoblotting. *p < 0.05, **p < 0.01, ***p < 0.001 Overexpression of MARCHF1 or MARCHF3 can reverse NLRP3 inflammasome-mediated pyroptosis activated by Aβ1−42 The above results show that Aβ1−42 decreased MARCHF1 or MARCHF3 expression and increased the NLRP3 expression. Next, we further investigated whether MARCHF1 or MARCHF3 mediated the regulatory effect of Aβ1−42 in SH-SY5Y cells. SH-SY5Y cells were treated with 10 µM Aβ1−42, followed by transfection with MARCHF1 or MARCHF3 plasmid. Then the NLRP3 expression was tested. We found that the increase of NLRP3 expression by Aβ1−42 treatment was not inhibited by MARCHF1 or MARCHF3 overexpression in SH-SY5Y cells (Fig. 4A). MG132 treatment reversed the downregulation of NLRP3 caused by MARCHF1 or MARCHF3 overexpression (Fig. 4B). Western blotting results showed an increase of GSDMD-NT, and cleaved caspase-1 protein expression levels in the Aβ1−42 treatment, but this effect was reversed by MARCHF1 or MARCHF3 overexpression (Fig. 4C-E). ELISA results showed that Aβ1−42 treatment increased the release of IL-1β and IL-18, but this effect was reversed by MARCHF1 or MARCHF3 overexpression (Fig. 4F-G). Next, we investigated the role of Aβ1−42 and MARCHF1 or MARCHF3 on the proliferation of SH-SY5Y cells. Aβ1−42 can decrease the OD values of SH-SY5Y cells, while MARCHF1 or MARCHF3 overexpression can reverse this effect (Fig. 4H). Flow cytometry showed the similar results (Fig. 4I). All these results showed that Aβ1−42 promoted SH-SY5Y cells pyroptosis, and this process was mediated by MARCHF1 or MARCHF3. Overexpression of MARCHF1 or MARCHF3 can reverse NLRP3 inflammasome-mediated pyroptosis activated by Aβ1−42 (A) The SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected 72 h later, and the NLRP3 mRNA was tested by qRT-PCR. (B) The SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 4 h before harvest, 20 µM MG132 was added. Western blot was used to test the NLRP3 protein expression level in SH-SY5Y cells. (C-E) The SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 72 h later, Western blot was used to test the cleaved-caspase 1 and GSDMD-N protein expression level in SH-SY5Y cells. (F). The SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 72 h later, ELISA was to test the expression of IL-1β in SH-SY5Y cells. (G) The SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 72 h later, ELISA was used to test the expression of IL-18 in SH-SY5Y cells. (H) The SH-SY5Y cells were treated with 10 µM Aβ1–42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 72 h later, CCK8 assay was used to test the cell viability of SH-SY5Y cells. (I) The SH-SY5Y cells were treated with 10 µM Aβ1−42 for 24 h, then the MARCHF1 or MARCHF3 plasmid was transfected. 72 h later, flow cytometry was used to test the cell apoptosis of SH-SY5Y cells. *p < 0.05, **p < 0.01, ***p < 0.001 Bushen Huoxue acupuncture upregulated MARCHF1 or MARCHF3 expression in AD Mice As Bushen Huoxue Acupuncture inhibited NLRP3 inflammasome-mediated pyroptosis in AD mice and overexpression of MARCHF1 or MARCHF3 can reverse NLRP3 inflammasome mediated hippocampus neuronal pyroptosis activated by Aβ1−42, we next tested the Bushen Huoxue Acupuncture’s effects on the expression of MARCHF1 or MARCHF3 in hippocampus tissues of AD mice. QRT-PCR results revealed that the MARCHF1 or MARCHF3 mRNA expression was decreased in hippocampus tissues of AD mice compared with control group. Bushen Huoxue Acupuncture increased MARCHF1 or MARCHF3 mRNA expression compared with the AD or AD + nonacupuncture group (Fig. 5A-B). IHC showed the similar results (Fig. 5C-E). All these results showed that Bushen Huoxue Acupuncture upregulated MARCHF1 or MARCHF3 expression in hippocampus tissues of AD mice compared with control group. Bushen Huoxue acupuncture upregulated MARCHF1 or MARCHF3 expression in AD Mice (A) QRT-PCR was used to test the MARCHF1 mRNA level in mice with different treatments. (B) QRT-PCR was used to test the MARCHF3 mRNA level in mice with different treatments. (C-E) TUNEL staining was used to test MARCHF1 or MARCHF3 expression in mice with different treatments. Data were presented as the mean value ± SD from at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 Discussion In the current study, Bushen Huoxue Acupuncture was performed in four acupoints of “Baihui”, “Shenshu”, “Xuehai”, and “Geshu” by manual acupuncture. Previous studies of electroacupuncture at Baihui and Shenshu acupoints reinforced hippocampal synaptic transmission and improved spatial memory ability in Alzheimer’s disease rats (Li et al. 2016; Yu et al. 2018). Electroacupuncture the acupoint “Baihui” (GV20) inhibits the activation of glia and polarizes microglia toward the M2 phenotype and improves the recognition abilities and memory of Alzheimer’s disease (AD) rats (Xie et al. 2021). However, the efficacy of acupuncture at the acupoints of “Xuehai” and “Geshu” for AD remains not fully understood. In this study, Bushen Huoxue Acupuncture protected cognitive impairment in AD mice. Our results confirmed the potential of acupuncture at the acupoints of “Baihui”, “Shenshu”, “Xuehai”, and “Geshu” for AD treatment. In AD, Amyloid-β (Aβ) induces neuronal pyroptosis, and the expression of GSDMD is increased (Shen et al. 2021; Tan et al. 2014). Further studies showed pyroptosis was a candidate therapeutic target for AD (Huang et al. 2022). Pyroptosis is a lytic and inflammatory type of programmed cell death that is usually triggered by inflammasomes and executed by gasdermin proteins (Rao et al. 2022). The assembled NLRP3 inflammasome can activate the protease caspase-1, the caspase-1 then cleave gasdermin D (GSDMD) in its middle linker to release autoinhibition on its gasdermin-N domain, which executes pyroptosis via its pore-forming activity (Huang et al. 2021; Wang et al. 2017). Compound diarylheptanoid C1 can mitigate AD-like pathology via the inhibition of pyroptosis (Shi et al. 2024). miR-212-3p attenuates neuroinflammation of rats with Alzheimer’s disease via regulating neuronal pyroptosis (Nong et al. 2022). Here, we found that Bushen Huoxue Acupuncture upregulated MARCHF1 or MARCHF3 expression, and inhibited NLRP3 inflammasome mediated hippocampal neuronal pyroptosis and the secretion of inflammatory cytokines in vivo. Ubiquitin can be attached to other proteins at either a lysine residue or to the N-terminus by the consecutive actions of E1, E2, and E3 enzymes (Leestemaker and Ovaa 2017). E3 ligases can be classified into three main types depending on the presence of characteristic domains and on the mechanism of ubiquitin transfer to the substrate protein: RING E3s, HECT E3s and RBR E3s (Morreale and Walden 2016). Membrane-associated RING‐CH‐5 (MARCH5) is a ring-finger E3 ubiquitin ligase located in the outer membrane of, can interact with the NACHT domain of NLRP3 and promotes K27-linked polyubiquitination on K324 and K430 residues of NLRP3 (Park et al. 2023; Xu et al. 2024).In this study, we found that Aβ1−42 decreased the binding of E3 ubiquitin-protein ligase MARCHF1 or MARCHF3 with NLRP3, and the ubiquitination of NLRP3. Conclusion In conclusion, our data demonstrated that the relationship between NLRP3 inflammasome-mediated pyroptosis and AD. Bushen Huoxue Acupuncture had a prominent preventive effect on the pathogenesis of AD. It effectively ameliorated AD by upregulating MARCHF3 to induce NLRP3 ubiquitination and inhibited caspase-1-dependent pyroptosis. Consequently, Bushen Huoxue Acupuncture may be a potential candidate for the treatment of AD through inhibiting the NLRP3 inflammasome-mediated pyroptosis. Schemetic diagram of the study Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Abbreviations Alzheimer’s disease Amyloid Amyloid precursor protein donepezil Enzyme-Linked Immunosorbent Assay gasdermin D Immunohistochemical staining Membrane-associated RING‐CH‐1 quantitative real-time PCR Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling Author contributions Hong Zhu: Conceptualization, Data curation, Formal analysis, Investigation, Writing-original draft, Writing-review & editing. Ting Zhang: Conceptualization, Data curation, Formal analysis, Writing-original draft, Writing-review & editing. Ruomeng Li: Investigation, Methodology, Writing-original draft, Writing-review & editing. Dan Ren: Investigation, Methodology, Writing-review & editing. Jiangxi Xu: Software, Validation, Writing-review & editing. Lan Xiao: Funding acquisition, Project administration, Resources, Supervision, Writing-review & editing. Funding This work was supported by Hunan Provincial Natural Science Foundation of China (2021JJ31029, 2023JJ30862), The 14th Five-Year Plan of Hunan Province TCM Discipline Leader Training Project, The 14th Five-Year Plan of Hunan Province TCM Backbone Talent Training Project. Data availability All data generated and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Consent for publication The data used in this study has never been published before. Competing interests The authors declare no competing interests. Conflict of interest The authors declare that they have no competing interests. Ethics approval All animal experiments were conducted with the approval of the Experimental Animal Ethics Committee of The Third Xiangya Hospital of Central South University. All protocols were performed under conditions to minimize animal suffering. Consent to participate Not applicable. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement All data generated and/or analyzed during the current study are available from the corresponding author on reasonable request.